脂肪酸结合蛋白4与DNA甲基转移酶1的恶性循环促进急性髓系白血病并可作为治疗靶点
研究揭示急性髓系白血病(AML)细胞中FABP4上调由VEGF信号介导,形成FABP4-DNMT1调控反馈环路;选择性抑制剂BMS309403在体外、离体和体内下调DNMT1、降低整体DNA甲基化、重新表达p15INK4B,抑制集落形成、诱导分化并延缓小鼠白血病进展。
要点
- AML细胞中VEGF信号上调FABP4,进而增强DNMT1依赖的DNA甲基化。
- BMS309403抑制FABP4后下调DNMT1、降低整体DNA甲基化并重新表达p15INK4B。
- BMS309403抑制集落形成、诱导分化并延缓小鼠白血病进展。
核心结论
- FABP4-DNMT1恶性循环具有促进AML的特性,并识别出一类高潜力临床使用的治疗药物。
- 研究结果将协助确立FABP4-DNMT1环路作为治疗发现靶点,以提升当前表观遗传治疗的指数。
研究设计与样本
- 研究在体外、离体和体内及小鼠白血病模型中开展,检测FABP4选择性抑制剂BMS309403的作用。
- 原文未报告样本量、分组及具体研究类型。
主要发现
- AML细胞中FABP4上调通过VEGF信号发生,从而阐明FABP4-DNMT1调控反馈环路。
- BMS309403导致DNMT1下调、整体DNA甲基化降低及p15INK4B肿瘤抑制基因启动子DNA低甲基化重新表达,在体外、离体和体内均如此。
- BMS309403抑制细胞集落形成、诱导细胞分化,并在小鼠白血病模型中损害白血病疾病进展。
关键数值与推荐
- 原文未报告具体数值、阈值或推荐等级。
临床怎么用
- 原文结论未据此给出临床推荐,仅指出BMS309403代表一类高潜力临床使用的治疗药物。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Aberrant DNA methylation mediated by deregulation of DNA methyltransferases (DNMT) is a key hallmark of acute myeloid leukemia (AML), yet efforts to target DNMT deregulation for drug development have lagged. We previously demonstrated that upregulation of fatty acid-binding protein 4 (FABP4) promotes AML aggressiveness through enhanced DNMT1-dependent DNA methylation. Here, we demonstrate that FABP4 upregulation in AML cells occurs through vascular endothelial growth factor (VEGF) signaling, thus elucidating a crucial FABP4-DNMT1 regulatory feedback loop in AML biology. We show that FABP4 dysfunction by its selective inhibitor BMS309403 leads to downregulation of DNMT1, decrease of global DNA methylation and re-expression of p15INK4B tumor suppressor gene by promoter DNA hypomethylation in vitro, ex vivo and in vivo. Functionally, BMS309403 suppresses cell colony formation, induces cell differentiation, and, importantly, impairs leukemic disease progression in mouse models of leukemia. Our findings highlight AML-promoting properties of the FABP4-DNMT1 vicious loop, and identify an attractive class of therapeutic agents with a high potential for clinical use in AML patients. The results will also assist in establishing the FABP4-DNMT1 loop as a target for therapeutic discovery to enhance the index of current epigenetic therapies.
引用
- Yan F, Shen N, Pang JX, et al. A vicious loop of fatty acid-binding protein 4 and DNA methyltransferase 1 promotes acute myeloid leukemia and acts as a therapeutic target. Leukemia. 2017. PMID: 28993705. doi:10.1038/leu.2017.307
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。